Ligua Past Earnings Performance
Past criteria checks 2/6
Ligua's earnings have been declining at an average annual rate of -56.2%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 9.1% per year. Ligua's return on equity is 17.2%, and it has net margins of 3%.
Key information
-56.2%
Earnings growth rate
-57.3%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 9.1% |
| Return on equity | 17.2% |
| Net Margin | 3.0% |
| Next Earnings Update | 08 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Ligua makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 3,430 | 104 | 1,761 | 0 |
| 31 Dec 23 | 3,487 | -310 | 1,737 | 0 |
| 30 Sep 23 | 3,208 | -582 | 1,708 | 0 |
| 30 Jun 23 | 3,027 | -713 | 1,728 | 0 |
| 31 Mar 23 | 2,837 | -774 | 1,732 | 0 |
| 31 Dec 22 | 2,638 | -413 | 1,703 | 0 |
| 30 Sep 22 | 2,779 | -225 | 1,644 | 0 |
| 30 Jun 22 | 3,014 | -90 | 1,575 | 0 |
| 31 Mar 22 | 3,202 | 72 | 1,476 | 0 |
| 31 Dec 21 | 3,322 | 119 | 1,465 | 0 |
| 30 Sep 21 | 3,113 | 87 | 1,379 | 0 |
| 30 Jun 21 | 2,832 | 93 | 1,285 | 0 |
| 31 Mar 21 | 2,687 | 157 | 1,194 | 0 |
| 31 Dec 20 | 2,534 | 193 | 1,088 | 0 |
| 31 Mar 20 | 2,167 | 142 | 1,008 | 0 |
| 31 Mar 19 | 1,809 | 35 | 985 | 0 |
| 31 Mar 18 | 1,470 | 73 | 750 | 0 |
Quality Earnings: 7090 has a large one-off gain of ¥30.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 7090 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7090 has become profitable over the past 5 years, growing earnings by -56.2% per year.
Accelerating Growth: 7090 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 7090 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (7.1%).
Return on Equity
High ROE: 7090's Return on Equity (17.2%) is considered low.